Has Chibuzo Okoye, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,544 in general payments to Chibuzo Okoye, MD across 40 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Chibuzo Okoye, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Chibuzo Okoye, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Chibuzo Okoye, MD

Internal Medicine · Brooklyn, NYNPI 1659831469

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,800 of the $10,544 with a category attached, or 74.0%. GSK accounts for 89.6% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $8,055, more than ten times the $297 reported in 2022. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,544in general payments, 2019–2025

Across 40 payments — averaging $263.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$9K
AstraZeneca$767
Aurinia Pharma U.S., Inc.$107
Boehringer Ingelheim$68
Actelion Pharmaceuticals US, Inc.$46
Vifor Pharma, Inc.$43
plus $70 from 3 others

What the payments were for

Consulting fees$7,80074%
Travel & lodging$1,31913%
Food & beverage$1,42514%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	14	$9,445
AstraZeneca	11	$767
Aurinia Pharma U.S., Inc.	6	$107
Boehringer Ingelheim	2	$68
Actelion Pharmaceuticals US, Inc.	2	$46
Vifor Pharma, Inc.	2	$43
CSL Behring	1	$28
Akebia Therapeutics Inc	1	$23
Haemonetics Corporation	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SHINGRIX$7,938
LOKELMA$618
BENLYSTA$103

How this compares

$10,544 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York →

Medicare billing

Part B allowed, 2024

$18,366

Medicare patients

109

Services billed

129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Brooklyn

Bruce BergerBrooklyn$3.4M
Jesi RamoneBrooklyn$627K
Manish ParikhBrooklyn$236K
Samuel UterBrooklyn$136K
David DoveEast Hampton$12.3M
Nicholas RobinsonBuffalo$2.9M
Stephen SaletanNew York$2.6M
Ziad AliNew York$2M
Scott BeegleAlbany$1.9M
Anthony MartinezBuffalo$1.6M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →